MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Comprehensive integration of single-cell data. A comparison study: applying segmentation to array CGH data for downstream analyses. Circular binary segmentation for the analysis of array-based DNA copy number data. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Molecular signatures database (MSigDB) 3.0. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. GSVA: gene set variation analysis for microarray and RNA-seq data. COSMIC: somatic cancer genetics at high-resolution. Comprehensive molecular portraits of human breast tumours. The somatic genomic landscape of glioblastoma. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. New diagnostic and management approaches in endocrine pathology. Endocrine pathology: advances, updates, and diagnostic pearls. Molecular Pathology of Endocrine Diseases (Springer, 2010).īarletta, J. Cytokeratin-8 in anaplastic thyroid carcinoma: more than a simple structural cytoskeletal protein. Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples. Identification of targetable lesions in anaplastic thyroid cancer by genome profiling. Co-clinical assessment of tumor cellularity in pancreatic cancer. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems. Integrated genomic characterization of the kallikrein gene locus in cancer. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Pancreas 42, 1016–1026 (2013).Ĭancer Genome Atlas Research Network. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Genome-wide copy number analysis of single cells. Transformations related to the angular and the square root. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data. Genomic and functional approaches to understanding cancer aneuploidy. Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer. Massively parallel digital transcriptional profiling of single cells. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. These data show that CopyKAT can aid in the analysis of scRNA-seq data in a variety of solid human tumors. In three breast tumors, CopyKAT resolved clonal subpopulations that differed in the expression of cancer genes, such as KRAS, and signatures, including epithelial-to-mesenchymal transition, DNA repair, apoptosis and hypoxia. We applied CopyKAT to analyze 46,501 single cells from 21 tumors, including triple-negative breast cancer, pancreatic ductal adenocarcinoma, anaplastic thyroid cancer, invasive ductal carcinoma and glioblastoma, to accurately (98%) distinguish cancer cells from normal cell types. To address these challenges, we developed an integrative Bayesian segmentation approach called copy number karyotyping of aneuploid tumors (CopyKAT) to estimate genomic copy number profiles at an average genomic resolution of 5 Mb from read depth in high-throughput single-cell RNA sequencing (scRNA-seq) data. However, it remains challenging to distinguish normal cell types in the tumor microenvironment from malignant cells and to resolve clonal substructure within the tumor. Single-cell transcriptomic analysis is widely used to study human tumors.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |